Primary biliary cirrhosis exacerbated by a course of acute hepatitis C and subsequent interferon therapy.
Yoshikawa
M
M
Mimura
M
M
Shiroi
A
A
Kojima
H
H
Fukui
H
H
Sugimoto
Y
Y
Mochi
T
T
D000208:Acute Disease; D000998:Antiviral Agents / Q000008:administration & dosage / Q000009:adverse effects*; D001706:Biopsy; D018562:Disease Transmission, Infectious; D005260:Female; D016174:Hepacivirus / Q000235:genetics; D006526:Hepatitis C / Q000150:complications / Q000188:drug therapy* / Q000635:transmission; D006801:Humans; D007279:Injections, Subcutaneous; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000008:administration & dosage / Q000009:adverse effects*; D008105:Liver Cirrhosis, Biliary / Q000201:enzymology / Q000209:etiology* / Q000473:pathology; D008875:Middle Aged; D016602:Needlestick Injuries / Q000150:complications; D012367:RNA, Viral / Q000032:analysis; D011994:Recombinant Proteins; D000637:Transaminases / Q000097:blood
D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D012367:RNA, Viral; D011994:Recombinant Proteins; D000637:Transaminases